Transcriptomics

Dataset Information

0

Analysis of gene expression in human adipose tissue-derived multipotent mesenchymal stromal cells lacking GARP/LRRC32


ABSTRACT: Multipotent mesenchymal stromal cells (MSCs) have been shown to promote tissue repair and inhibit inflammatory/autoimmune responses in preclinical and human clinical trials A major problem for MSC-based therapies is the need to expand MSCs in vitro due to the low frequency of MSCs in tissues and the large numbers of cells needed/patient (1-10 x 10^6 cells/kg). The expansion of MSCs is associated with several problems including loss of homing capacity, onset of cellular senescence, decrease in differentiation capacityand susceptibility to genomic instability and malignant transformation, limiting the utility of MSCs as a cell-based therapy. We have recently reported that murine adipose tissue-derived MSCs (mASCs) and human ASCs (hASCs) express glycoprotein A repetitions predominant (GARP)/leucine-rich repeat-containing 32 (LRRC32). GARP binds LAP/TGF-β1 to the surface of mASCs and hASCs, regulating their secretion and activation of TGF-β1 and promoting their immunomodulatory capacity. Interestingly, silencing of GARP in ASCs significantly decreased their proliferative capacity but the mechanisms remain unknown. As the proliferative capacity of MSCs is fundamental for their success in therapy, we have aimed at understanding how GARP modulates the expansion of MSC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE104254 | GEO | 2019/06/05

SECONDARY ACCESSION(S): PRJNA412175

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2020-08-31 | GSE150008 | GEO
2013-01-28 | E-GEOD-43803 | biostudies-arrayexpress
2013-01-27 | E-GEOD-43781 | biostudies-arrayexpress
2016-07-01 | E-GEOD-74203 | biostudies-arrayexpress
2013-01-28 | GSE43803 | GEO
2013-01-27 | GSE43781 | GEO
2024-10-17 | PXD035803 | Pride
2016-07-01 | GSE74203 | GEO
2024-04-30 | GSE202320 | GEO
2010-11-01 | GSE18879 | GEO